BioSpace News Archive

MedCrypt Inc., the leading provider of proactive security solutions for the healthcare space, today announced the addition of Michael McNeil to its board of directors.

Bikers invited to take a complimentary ride on Saturday, October 10, courtesy of Blue Cross, to experience the benefits of outdoor exercise on mental health [07-October-2020] BOSTON , Oct. 7, 2020 /PRNewswire/ -- To recognize World Mental Health Day and to support community health and wellness, Blue Cross Blue Shield of Massachusetts (“Blue Cross”) is sponsori

The American Society of Transplantation is proud to announce its new Living Donor Circle of Excellence program.

On Saturday, October 17, 2020, beginning at 8:30 am PDT, the San Diego Academy of Regenerative Therapies (SDARTs) will host a 90-minute Zoom expert Panel Discussion focused on the rationale and protocol for this FDA Oversight Trial. “The human race faces a viral pandemic which attacks the lungs, and eventually other systems, leaving permanent damage in the essential gas exchange funct

Curtana Pharmaceuticals, a privately-held, preclinical stage biopharmaceutical company, today announced that the Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) designation to CT-179, the company’s lead Olig2 inhibitor, for the treatment of medulloblastoma (MB).

Infosys Public Services, a US-based subsidiary of Infosys (NYSE: INFY), a global leader in next-generation digital services and consulting, today unveiled the Infosys Health Insights Platform (IHIP) – an automated data science platform for public health agencies developed in collaboration with Amazon Web Services (AWS), Couchbase, and Knowi.

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement today:

The Medical Device Innovation Consortium (MDIC) announced today that the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) will participate in its Case for Quality Collaborative Community (CfQcc) initiative.

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Professor Emmanuelle Charpentier, congratulates Emmanuelle on being awarded the 2020 Nobel Prize in Chemistry for her groundbreaking work on the CRISPR-Cas9 system.

Capillary Biomedical, Inc. (CapBio) has announced that it has received a $1.5 million program-related investment in the form of a loan from The Leona M. and Harry B. Helmsley Charitable Trust (Helmsley). The use of funds includes clinical studies of CapBio’s